2014 ACBS Landline-Cellphone Combined Prevalence Tables
ShareCompartir
TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line And Cell Phone Combined Sample, United States, 2014
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Connecticut | 210 | 51.2 | 6.0 | (39.4 – 63.0) | 225 | 52.0 | 5.9 | (40.4 – 63.6) |
| District of Columbia | 108 | 54.7 | 11.1 | (32.9 – 76.5) | 111 | 62.1 | 9.9 | (42.7 – 81.5) |
| Georgia | 132 | 35.8 | 6.7 | (22.7 – 48.9) | 138 | 36.8 | 6.7 | (23.7 – 49.9) |
| Hawaii | 185 | 49.4 | 6.3 | (37.1 – 61.7) | 195 | 47.0 | 6.0 | (35.2 – 58.8) |
| Illinois | 187 | 53.5 | 5.4 | (42.9 – 64.1) | 202 | 50.6 | 5.1 | (40.6 – 60.6) |
| Indiana | 488 | 58.9 | 3.3 | (52.4 – 65.4) | 509 | 55.4 | 3.4 | (48.7 – 62.1) |
| Iowa | 228 | 51.5 | 4.9 | (41.9 – 61.1) | 251 | 50.4 | 4.6 | (41.4 – 59.4) |
| Maine | 290 | 54.9 | 4.3 | (46.5 – 63.3) | 312 | 51.3 | 4.1 | (43.3 – 59.3) |
| Maryland | 209 | 53.9 | 6.1 | (41.9 – 65.9) | 218 | 52.8 | 5.8 | (41.4 – 64.2) |
| Michigan | 414 | 54.1 | 3.5 | (47.2 – 61.0) | 444 | 52.1 | 3.2 | (45.8 – 58.4) |
| Mississippi | 128 | 57.9 | 6.6 | (45.0 – 70.8) | 135 | 50.8 | 6.9 | (37.3 – 64.3) |
| Missouri | 255 | 62.2 | 4.8 | (52.8 – 71.6) | 260 | 63.2 | 4.7 | (54.0 – 72.4) |
| Montana | 253 | 50.5 | 5.2 | (40.3 – 60.7) | 264 | 47.4 | 5.1 | (37.4 – 57.4) |
| Nebraska | 681 | 46.8 | 3.4 | (40.1 – 53.5) | 718 | 43.2 | 3.4 | (36.5 – 49.9) |
| Nevada | 130 | 57.2 | 6.3 | (44.9 – 69.5) | 148 | 52.1 | 6.0 | (40.3 – 63.9) |
| New Hampshire | 219 | 51.2 | 4.7 | (42.0 – 60.4) | 228 | 48.7 | 5.0 | (38.9 – 58.5) |
| New Jersey | 420 | 42.6 | 3.9 | (35.0 – 50.2) | 448 | 41.5 | 3.7 | (34.2 – 48.8) |
| New Mexico | 230 | 53.8 | 5.3 | (43.4 – 64.2) | 258 | 49.4 | 4.8 | (40.0 – 58.8) |
| New York | 115 | 50.9 | 7.0 | (37.2 – 64.6) | 118 | 50.9 | 7.2 | (36.8 – 65.0) |
| North Carolina | 130 | 52.0 | 8.2 | (35.9 – 68.1) | 137 | 55.7 | 7.3 | (41.4 – 70.0) |
| Ohio | 337 | 48.3 | 4.2 | (40.1 – 56.5) | 359 | 45.6 | 4.0 | (37.8 – 53.4) |
| Oklahoma | 229 | 44.1 | 4.3 | (35.7 – 52.5) | 219 | 50.3 | 4.6 | (41.3 – 59.3) |
| Oregon | 165 | 42.0 | 6.7 | (28.9 – 55.1) | 191 | 37.9 | 5.9 | (26.3 – 49.5) |
| Pennsylvania | 413 | 50.5 | 4.0 | (42.7 – 58.3) | 431 | 48.7 | 3.8 | (41.3 – 56.1) |
| Rhode Island | 189 | 61.5 | 5.7 | (50.3 – 72.7) | 211 | 57.9 | 5.5 | (47.1 – 68.7) |
| Texas | 465 | 54.2 | 4.3 | (45.8 – 62.6) | 525 | 48.1 | 3.9 | (40.5 – 55.7) |
| Utah | 507 | 47.1 | 2.9 | (41.4 – 52.8) | 544 | 45.0 | 2.8 | (39.5 – 50.5) |
| Vermont | 240 | 62.8 | 3.7 | (55.5 – 70.1) | 254 | 59.6 | 3.8 | (52.2 – 67.0) |
| Washington | 374 | 60.7 | 4.3 | (52.3 – 69.1) | 389 | 51.6 | 5.1 | (41.6 – 61.6) |
| West Virginia | 237 | 54.5 | 4.2 | (46.3 – 62.7) | 236 | 56.4 | 4.2 | (48.2 – 64.6) |
| Wisconsin | 246 | 51.0 | 5.2 | (40.8 – 61.2) | 254 | 54.1 | 5.1 | (44.1 – 64.1) |
| Puerto Rico | 352 | 30.3 | 3.3 | (23.8 – 36.8) | 390 | 31.0 | 3.2 | (24.7 – 37.3) |
| 32 state total | 8,766 | 51.1 | 1.3 | (48.6 – 53.6) | 9,322 | 49.5 | 1.3 | (47.0 – 52.0) |
| Median | 51.8 | 50.7 | ||||||
| Range | 30.3-62.8 | 31.0-63.2 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
- Page last reviewed: February 14, 2017
- Page last updated: February 14, 2017
- Content source: